On 5th November 2010 the FDA approved Kombiglyze XR from BMS/AstraZeneca, for the treatment of type 2 diabetes in adults....
AstraZeneca announced an agreement under which AstraZeneca will acquire the entirety of Bristol-Myers Squibb�s interests in the companies� diabetes alliance...
The FDA has requested data from AstraZeneca as part of its investigation a possible association between use of Onglyza for...
The FDA has approved Quillivant XR (methylphenidate hydrochloride) from Next Wave Pharma for extended-release oral suspension for treatment of Attention...
Veloxis Pharmaceuticals A/S announced that Envarsus XR (extended release tacrolimus) was granted Orphan Drug status by the U.S. Food and...
Pfizer has announced that the FDA has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets for the once-daily treatment...
The Federal Patent Court in Germany has found the formulation patent protecting Seroquel XR (quetiapine fumarate) prolonged-release tablets � marketed...